Cell Therapeutics pays $11.2 million, retires all 5.75% convertibles

By Tali David

Minneapolis, Dec. 19 - Cell Therapeutics, Inc. deposited $11.2 million in cash as trust funds of its 5.75% convertible senior notes to pay and retire the entire amount due on the notes, including accrued interest, according to a news release.

The company has now retired all of its outstanding convertible debt.

U.S. Bank, NA is the trustee.

Cell Therapeutics is a Seattle-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.